Evidence map›Paper›PMID 32568414›Full record

ArticleAllergy2021

Cross-reactive carbohydrate determinant-specific IgE obscures true atopy and exhibits ⍺-1,3-fucose epitope-specific inverse associations with asthma.

Gyaviira Nkurunungi, Harriet Mpairwe, Serge A Versteeg, Angela van Diepen, Jacent Nassuuna, Joyce Kabagenyi, Irene Nambuya, Richard E Sanya, Margaret Nampijja, Sonia Serna and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Serum antibody screening using glycan arrays.Chemical Society reviews · 2024
    Review
  7. Observational
  8. Review
  9. Article
  10. Allergen skin test reactivity and asthma are inversely associated with ratios of IgG4/IgE and total IgE/allergen-specific IgE in Ugandan communities.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Article
  11. Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Article
  12. Observational
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Gyaviira NkurunungiImmunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.ORCID 0000-0003-4062-9105
Harriet MpairweImmunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Serge A VersteegDepartments of Experimental Immunology and of Otorhinolaryngology, Amsterdam University Medical Centers (AMC), Amsterdam, The Netherlands.
Angela van DiepenDepartment of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Jacent NassuunaImmunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Joyce KabagenyiImmunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Irene NambuyaImmunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Richard E SanyaImmunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Margaret NampijjaImmunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Sonia SernaGlycotechnology Laboratory, Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE), San Sebastián, Spain.
Niels-Christian ReichardtGlycotechnology Laboratory, Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE), San Sebastián, Spain.
Cornelis H HokkeDepartment of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Emily L WebbDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, MRC Tropical Epidemiology Group, London, UK.ORCID 0000-0002-4019-7456
Ronald van ReeDepartments of Experimental Immunology and of Otorhinolaryngology, Amsterdam University Medical Centers (AMC), Amsterdam, The Netherlands.
Maria YazdanbakhshDepartment of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Alison M ElliottImmunomodulation and Vaccines Programme, Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI and LSHTM) Uganda Research Unit, Entebbe, Uganda.
Uganda Virus Research Institute · UGLeiden University Medical Center · NLLondon School of Hygiene & Tropical Medicine · GBAmsterdam University Medical Centers · NLCIC biomaGUNE · ESMakerere University · UG

Funding

Medical Research Council MC_UU_00027/5Wellcome Trust 095778Wellcome Trust 102512Wellcome Trust 102512/Z/13/ZWellcome Trust 107743
6 · The paper itself

Abstract

backgroundIn high-income, temperate countries, IgE to allergen extracts is a risk factor for, and mediator of, allergy-related diseases (ARDs). In the tropics, positive IgE tests are also prevalent, but rarely associated with ARD. Instead, IgE responses to ubiquitous cross-reactive carbohydrate determinants (CCDs) on plant, insect and parasite glycoproteins, rather than to established major allergens, are dominant. Because anti-CCD IgE has limited clinical relevance, it may impact ARD phenotyping and assessment of contribution of atopy to ARD.

methodsUsing an allergen extract-based test, a glycan and an allergen (glyco)protein microarray, we mapped IgE fine specificity among Ugandan rural Schistosoma mansoni (Sm)-endemic communities, proximate urban communities, and importantly in asthmatic and nonasthmatic schoolchildren.

resultsOverall, IgE sensitization to extracts was highly prevalent (43%-73%) but allergen arrays indicated that this was not attributable to established major allergenic components of the extracts (0%-36%); instead, over 40% of all participants recognized CCD-bearing components. Using glycan arrays, we dissected IgE responses to specific glycan moieties and found that reactivity to classical CCD epitopes (core β-1,2-xylose, α-1,3-fucose) was positively associated with sensitization to extracts, rural environment and Sm infection, but not with skin reactivity to extracts or sensitization to their major allergenic components. Interestingly, we discovered that reactivity to only a subset of core α-1,3-fucose-carrying N-glycans was inversely associated with asthma.

conclusionsCCD reactivity is not just an epiphenomenon of parasite exposure hampering specificity of allergy diagnostics; mechanistic studies should investigate whether specific CCD moieties identified here are implicated in the protective effect of certain environmental exposures against asthma.

Indexed as

AsthmaFucoseAllergensCarbohydratesChildCross ReactionsEpitopesHumansImmunoglobulin EAllergensCarbohydratesEpitopesFucoseImmunoglobulin Easthmacross-reactive carbohydrate determinantSchistosoma mansoniα-1,3-fucoseβ-1,2-xylose

Identifiers

PMID32568414
PMCPMC7610925
OpenAlexW3036772519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.